Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
Surgery followed by a chemotherapy agent is the first-line treatment for breast cancer patients.Nevertheless, new targets are required for women with triple-negative breast cancer (TNBC) Lash in order to improve the treatment of this aggressive cancer subtype.Multiple pro-inflammatory molecules including lipid-based substances such as sphingosine-1